DE60111259D1 - Membranfusion-proteine von reovirus - Google Patents

Membranfusion-proteine von reovirus

Info

Publication number
DE60111259D1
DE60111259D1 DE60111259T DE60111259T DE60111259D1 DE 60111259 D1 DE60111259 D1 DE 60111259D1 DE 60111259 T DE60111259 T DE 60111259T DE 60111259 T DE60111259 T DE 60111259T DE 60111259 D1 DE60111259 D1 DE 60111259D1
Authority
DE
Germany
Prior art keywords
proteins
isolated
membrane fusion
protein
reovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111259T
Other languages
English (en)
Inventor
Roy Duncan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUSOGENIX Inc
Original Assignee
FUSOGENIX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUSOGENIX Inc filed Critical FUSOGENIX Inc
Application granted granted Critical
Publication of DE60111259D1 publication Critical patent/DE60111259D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
DE60111259T 2000-12-01 2001-11-30 Membranfusion-proteine von reovirus Expired - Lifetime DE60111259D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002325088A CA2325088A1 (en) 2000-12-01 2000-12-01 Novel membrane fusion proteins derived from poikilothermic reovirus
PCT/CA2001/001702 WO2002044206A2 (en) 2000-12-01 2001-11-30 Membrane fusion proteins derived from reovirus

Publications (1)

Publication Number Publication Date
DE60111259D1 true DE60111259D1 (de) 2005-07-07

Family

ID=4167549

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111259T Expired - Lifetime DE60111259D1 (de) 2000-12-01 2001-11-30 Membranfusion-proteine von reovirus

Country Status (8)

Country Link
US (4) US20040044185A1 (de)
EP (1) EP1339747B1 (de)
JP (1) JP4350374B2 (de)
AT (1) ATE296838T1 (de)
AU (1) AU2002220415A1 (de)
CA (1) CA2325088A1 (de)
DE (1) DE60111259D1 (de)
WO (1) WO2002044206A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7915230B2 (en) 2005-05-17 2011-03-29 Molecular Transfer, Inc. Reagents for transfection of eukaryotic cells
CA2960570C (en) * 2006-05-05 2018-05-08 Molecular Transfer, Inc. Lipids for transfection of eukaryotic cells
EP2349296B1 (de) * 2008-08-21 2017-04-05 Ottawa Hospital Research Institute Manipulierte synergistische onkolytische virensymbiose
EP2482825B1 (de) * 2009-10-02 2016-11-23 The Trustees of Columbia University in the City of New York Diagnostische fisch-reoviren-zusammensetzungen
CA2813300A1 (en) 2010-09-29 2012-04-05 Innovascreen Inc. Recombinant polypeptides for membrane fusion and uses thereof
CN102675469A (zh) * 2012-03-08 2012-09-19 福建省农业科学院畜牧兽医研究所 新型鸭呼肠孤病毒重组σB(SigmaB)蛋白抗原、制备方法及应用
BR112015024605A2 (pt) 2013-03-24 2017-07-18 Oisin Biotechnologies sistemas e métodos para a produção visada de proteína terapêutica dentro de célula alvo
CA3047140A1 (en) 2017-01-09 2018-07-12 Oisin Biotechnologies Constructs for expression of therapeutic proteins in target cells
MX2019013312A (es) 2017-05-08 2020-08-17 Flagship Pioneering Innovations V Inc Composiciones para facilitar la fusion de membranas y usos de estas.
US11603543B2 (en) 2018-04-18 2023-03-14 Oisin Biotechnologies, Inc. Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein
AU2019269593A1 (en) * 2018-05-15 2020-11-26 Flagship Pioneering Innovations V, Inc. Fusosome compositions and uses thereof
WO2020014209A1 (en) * 2018-07-09 2020-01-16 Flagship Pioneering Innovations V, Inc. Fusosome compositions and uses thereof
AU2019347666A1 (en) 2018-09-28 2021-03-25 President And Fellows Of Harvard College Cellular reprogramming to reverse aging and promote organ and tissue regeneration
CA3094859A1 (en) * 2020-10-01 2022-04-01 Entos Pharmaceuticals Inc. Proteolipid vesicles formulated with fusion associated small transmembrane proteins
WO2023196851A1 (en) 2022-04-06 2023-10-12 President And Fellows Of Harvard College Reversing aging of the central nervous system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870009A (en) * 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4493795A (en) * 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4952496A (en) * 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US5527928A (en) * 1994-09-30 1996-06-18 Nantz; Michael H. Cationic transport reagents
US5948889A (en) * 1996-05-21 1999-09-07 Case Western Reserve University Compositions and methods for screening antimicrobials
WO1999024582A1 (en) * 1997-11-07 1999-05-20 Dalhousie University Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
US6589503B1 (en) * 1998-06-20 2003-07-08 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy

Also Published As

Publication number Publication date
US7851595B2 (en) 2010-12-14
US20120322156A1 (en) 2012-12-20
AU2002220415A1 (en) 2002-06-11
US20110144313A1 (en) 2011-06-16
WO2002044206A2 (en) 2002-06-06
US8252901B2 (en) 2012-08-28
US20080124793A1 (en) 2008-05-29
EP1339747A2 (de) 2003-09-03
JP4350374B2 (ja) 2009-10-21
EP1339747B1 (de) 2005-06-01
US20040044185A1 (en) 2004-03-04
JP2004520019A (ja) 2004-07-08
WO2002044206A3 (en) 2002-10-03
ATE296838T1 (de) 2005-06-15
CA2325088A1 (en) 2002-06-01

Similar Documents

Publication Publication Date Title
ATE296838T1 (de) Membranfusion-proteine von reovirus
ATE371727T1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
DK1133565T3 (da) Generering af specifikke bindingspartnere til (poly)peptider, som der kodes for af genomiske DNA-fragmenter eller EST'er
EA200700975A1 (ru) Рекомбинантный вирус ньюкаслской болезни
AR038568A1 (es) Anticuerpos anti-a beta y su uso
DE60335000D1 (de) In vitro peptid-expressionsbank
PT1007654E (pt) Biblioteca de expressao de proteina ou peptido in vitro
US20060240510A1 (en) Method for designing peptides
WO2003106650A3 (en) NUCLEIC ACIDS ENCODING CHD5, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
WO2002040683A3 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002046407A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
CO5400145A1 (es) Proteina asociada con enfermedad
NZ510812A (en) Novel peptides
WO2001081412A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
WO2002046406A3 (en) Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
AR112608A2 (es) Adn recombinante de epsp sintasa mejorada, vector y célula, polipéptido y método de uso
WO2002061062A3 (en) Human protein kinase n-like polypeptide and uses thereof
WO2002022678A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AR108848A1 (es) Genes de mini-distrofina optimizados y cassettes de expresión y su uso
WO2002057310A3 (en) Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
WO2002024910A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
WO2002020757A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002033086A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002046217A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002048365A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Legal Events

Date Code Title Description
8332 No legal effect for de